Auto-trilevel Ventilator for Patients With Overlap Syndrome

Status Completed

Clinical Trial Summary

Obstructive Sleep Apnea Syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two diseases that often coexist and are called overlap syndrome(OS). Compared to single OSAS, OS patients are more susceptible to serious hypoxia and hypercapnia especially during sleep, and are much more likely to result in pulmonary hypertension and cor-pulmonal.

With a more flexible expiratory positive airway pressure (EPAP), auto-trilevel ventilation may be superior to fixed bilevel positive airway pressure (BiPAP) ventilation in both removing residual obstructive sleep apnea hypopnea events and correcting hypercapnia simultaneously. The overall purpose of this study is to compare the curative effects between fixed BiPAP and auto-trilevel ventilations on OS patients.

Clinical Trial Description

The contradiction in treatment for overlap syndrome is how to improve hypercapnia because of narrower difference between inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), and meanwhile to eliminate apnea and popnea events which may easily occur at the end of expiration For ordinary Bipap ventilator. If the IPAP is set to higher, the patients may feel discomfort, if the pressure difference between IPAP and EPAP is too narrow or the expiratory positive airway pressure (EPAP) too high, hypercapnia may occur. If the EPAP is too low, redusual apnea and hypopnea event may become common.

Auto-trilevel ventilation, with a lower airway pressure at the beginning of expiration to prevent hypercapnia and a higher airway pressure at the end of expiration to prevent residual apnea events, should be able to provide a novel ventilation mode with a higher efficacy and lower average airway pressure for overlap syndrome. To prove the hypothesis, comparison is made between ordinary BiPAP and auto-Trilevel ventilation modes during treatment for patients with overlap syndrome.

In this study, the investigators compare the changes of related indexes including apnea hypopnea index、minimal pulse oxygen saturation、arousal index, sleep quality,PaCO2 and sleepiness scores) before and on treatment. Meanwhile, curative effects will be compared between BiPAP and auto-Trilevel ventilation modes. The investigators will analyze the changes and then confirm our hypothesis. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01523197
Study type	Interventional
Source	Nanjing Medical University
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	November 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04711200` - LYell SYndrome MEsenchymal Stromal Cells Treatment	Phase 1/Phase 2
Completed	`NCT02244957` - Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA	N/A
Not yet recruiting	`NCT05958563` - Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS)	N/A
Not yet recruiting	`NCT05190458` - Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome	N/A
Active, not recruiting	`NCT02488590` - Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases
Enrolling by invitation	`NCT05740306` - Irritable Bowel Syndrome Overlaping Celiac Disease
Completed	`NCT03069976` - "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"	N/A
Not yet recruiting	`NCT03766542` - Continuous Positive Pressure Versus Bi-level in Overlap Syndrome	N/A
Recruiting	`NCT03569826` - Canadian Network for Autoimmune Liver Disease
Recruiting	`NCT02363413` - Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome	N/A
Recruiting	`NCT05237505` - The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)	Phase 2
Not yet recruiting	`NCT01427673` - Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome	Phase 3
Recruiting	`NCT06377332` - Biomarkers of Dementia in Chronic Sleep and Breathing Disorders
Recruiting	`NCT04179981` - Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.